Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €38.74 EUR
Change Today -0.071 / -0.18%
Volume 0.0
HAZ On Other Exchanges
New York
As of 9:34 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

haemonetics corp/mass (HAZ) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/13/15 - €42.77
52 Week Low
04/30/14 - €21.71
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HAEMONETICS CORP/MASS (HAZ)

Related News

No related news articles were found.

haemonetics corp/mass (HAZ) Related Businessweek News

No Related Businessweek News Found

haemonetics corp/mass (HAZ) Details

Haemonetics Corporation is engaged in the design, development, manufacture, and marketing of automated blood component collection devices and surgical blood salvage devices in the United States and internationally. It provides various plasma products, including PCS brand plasma collection equipment and consumables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; and blood center products comprising multicomponent collection system brand apheresis equipment to collect specific blood components integrated from the donor, automated cell processor brand solution to automate the washing and freezing of red cell components in the lab, and filtration products. The company also offers various hospital products, such as TEG thrombelastograph hemostasis analyzer system that measures a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver system for cardiovascular surgery procedures; OrthoPAT surgical blood salvage system for orthopedic procedures; and IMPACT Online Web-based software platform that monitors and measures improvements in a hospital’s blood management practices. In addition, it offers SafeTrace Tx and BloodTrack suite of solutions, as well as El Dorado Donor donation and blood unit management systems. The company markets and sells its products to bio-pharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.

3,782 Employees
Last Reported Date: 05/22/14
Founded in 1971

haemonetics corp/mass (HAZ) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $600.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $718.0K
President of Global Plasma
Total Annual Compensation: $588.9K
Executive Vice President of Global Manufactur...
Total Annual Compensation: $455.0K
Chief Science & Technology Officer
Total Annual Compensation: $441.0K
Compensation as of Fiscal Year 2014.

haemonetics corp/mass (HAZ) Key Developments

Haemonetics Corporation and CSL Plasma, Inc. Announce Long-Term Plasma Collection Software Agreement

Haemonetics Corporation and CSL Plasma Inc. announced that CSL Plasma Inc. has selected Haemonetics' Next Generation Donor Management System as its future system for managing more than 100 plasma donation centers across the U.S. and Europe. The two companies completed a significant long-term technology agreement for a fully integrated software system designed to enable greater efficiency and to advance the collection operations performance.

Haemonetics Corporation Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 02:50 PM

Haemonetics Corporation Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 02:50 PM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, FL 32837, United States. Speakers: Brian P. Concannon, Chief Executive Officer, President and Director.

Haemonetics Corporation Opens New Manufacturing Facility in Penang, Malaysia

Haemonetics Corporation announced that it has opened a new manufacturing facility in Penang, Malaysia. To ensure the high energy efficiency and contaminant control environment, the company has incorporated clean rooms in the Malaysia facility. Key features include: anti-static raised floors, deionized air curtains, and enhanced personnel controls, such as dedicated undergarments and shoes, etc. As part of the company's business continuity plan, Malaysia's sister facility in Tijuana, Mexico is able to produce and ship the same products with the same high quality to customers in the Asia Pacific region should the need arise. The company is committed to operational excellence across the global manufacturing organization by employing lean manufacturing concepts in products, processes, and people.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HAZ:GR €38.74 EUR -0.071

HAZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $73.32 USD +0.27
Fresenius SE & Co KGaA €54.05 EUR +0.141
McKesson Corp $229.20 USD +0.09
Medtronic PLC $77.61 USD -0.89
Terumo Corp ¥3,215 JPY -20.00
View Industry Companies

Industry Analysis


Industry Average

Valuation HAZ Industry Range
Price/Earnings 75.4x
Price/Sales 2.4x
Price/Book 2.7x
Price/Cash Flow 74.4x
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAEMONETICS CORP/MASS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at